Search PubMedSearch

PubMed · 8117908

Global tests for multiple binary outcomes.

Abstract

The applied statistician often encounters the need to compare two or more groups with respect to more than one outcome or response. Several options are generally available, including reducing the dimension of the problem by averaging or summarizing the outcomes, using Bonferroni or other adjustments for multiple comparisons, or applying a global test based on a suitable multivariate model. For normally distributed data, it is well established that global tests tend to be significantly more sensitive than other procedures. While global tests have also been proposed for multiple binary outcomes, their properties have not been well studied nor have they been widely discussed in the context of clustered data. In this paper, we derive a class of quasi-likelihood score tests for multiple binary outcomes, and show that special cases of this class correspond to other tests that have been proposed. We discuss extensions to allow for clustered data, and compare the results to the simple approach of collapsing the data to a single binary outcome, indicating the presence or absence of at least one response. The asymptotic relative efficiencies of the tests are shown to depend not only on the correlation between the outcomes, but also on the response probabilities. Although global tests based on a multivariate model are generally recommended, our findings suggest that a test based on the collapsed data can maintain surprisingly high efficiency, especially when the outcomes of interest are rare. Data from several developmental toxicity studies illustrate our results.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Lefkopoulou, L Ryan. 1993. Global tests for multiple binary outcomes.. https://pubmed.ncbi.nlm.nih.gov/8117908/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The prevalence of fetal alcohol syndrome in New Zealand.

AIMS: To obtain an estimate of the prevalence of fetal alcohol syndrome in New Zealand and to report information on paediatrician surveillance for alcohol related birth defects. METHODS: New Zealand paediatricians were asked to complete a postal survey. Questions recorded the number of children with alcohol related birth defects under their care, and examined the respondents' surveillance for alcohol related birth defects. RESULTS: There were 63 children under 10 years of age with fetal alcohol syndrome under paediatric care in 1993. The majority of paediatricians considered the diagnosis only when risk features were identified: the most frequent being children of high risk mothers and children with dysmorphic features. CONCLUSIONS: Fetal alcohol syndrome exists in New Zealand. The prevalence of fetal alcohol syndrome as estimated in this study is lower than would be expected from international prevalence reports and is likely to be an underestimate. Current surveillance for alcohol related birth defects depends on an individual paediatrician considering the diagnosis only when faced with a perceived at risk infant or child, and there is likely under recognition. An increased awareness of the risks of alcohol consumption in pregnancy and the full spectrum of alcohol related birth defects is required.

Abnormalities, Drug-Induced

Teratogenicity of high vitamin A intake.

BACKGROUND: Studies in animals indicate that natural forms of vitamin A are teratogenic. Synthetic retinoids chemically similar to vitamin A cause birth defects in humans; as in animals, the defects appear to affect tissues derived from the cranial neural crest. METHODS: Between October 1984 and June 1987, we identified 22,748 pregnant women when they underwent screening either by measurement of maternal serum alpha-fetoprotein or by amniocentesis. Nurse interviewers obtained information on the women's diet, medications, and illnesses during the first trimester of pregnancy, as well as information on their family and medical history and exposure to environmental agents. We obtained information on the outcomes of pregnancy from the obstetricians who delivered the babies or from the women themselves. Of the 22,748 women, 339 had babies with birth defects; 121 of these babies had defects occurring in sites that originated in the cranial neural crest. RESULTS: For defects associated with cranial-neural-crest tissue, the ratio of the prevalence among the babies born to women who consumed more than 15,000 IU of preformed vitamin A per day from food and supplements to the prevalence among the babies whose mothers consumed 5000 IU or less per day was 3.5 (95 percent confidence interval, 1.7 to 7.3). For vitamin A from supplements alone, the ratio of the prevalence among the babies born to women who consumed more than 10,000 IU per day to that among the babies whose mothers consumed 5000 IU or less per day was 4.8 (95 percent confidence interval, 2.2 to 10.5). Using a smoothed regression curve, we found an apparent threshold near 10,000 IU per day of supplemental vitamin A. The increased frequency of defects was concentrated among the babies born to women who had consumed high levels of vitamin A before the seventh week of gestation. CONCLUSIONS: High dietary intake of preformed vitamin A appears to be teratogenic. Among the babies born to women who took more than 10,000 IU of preformed vitamin A per day in the form of supplements, we estimate that about 1 infant in 57 had a malformation attributable to the supplement.

Abnormalities, Drug-Induced